sulotroban has been researched along with u 44069 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beckerman, RC; Bellan, JA; Braquet, P; Dyson, MC; Kadowitz, PJ; McNamara, DB; Minkes, RK; Wegmann, MJ | 1 |
| Patscheke, H; Stegmeier, K | 2 |
| Deckmyn, H; Gresele, P; Janssens, WJ; Vermylen, J | 1 |
| Müller-Beckmann, B; Neugebauer, G; Patscheke, H; Sponer, G; Staiger, C; Stegmeier, K | 1 |
| Arnout, J; Deckmyn, H; Gresele, P; Janssens, W; Lemmens, J; Vermylen, J | 1 |
1 trial(s) available for sulotroban and u 44069
| Article | Year |
|---|---|
BM 13.177, a selective blocker of platelet and vessel wall thromboxane receptors, is active in man.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Blood Platelets; Blood Vessels; Clinical Trials as Topic; Double-Blind Method; Humans; Male; Platelet Aggregation; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Random Allocation; Receptors, Cell Surface; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Vasoconstriction | 1984 |
5 other study(ies) available for sulotroban and u 44069
| Article | Year |
|---|---|
Influence of SK&F 95587 and BN 50730 on bronchoconstrictor responses in the cat.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Azepines; Bronchoconstriction; Cats; Dose-Response Relationship, Drug; Female; Lung; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Prostaglandin Endoperoxides, Synthetic; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Prostaglandin; Receptors, Thromboxane; Respiration; Sulfonamides; Tetrazoles; Thienopyridines; Time Factors; Triazoles | 1990 |
Effects of the prostaglandin H2/thromboxane A2 antagonist BM 13.177 on human platelets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Aspirin; Blood Platelets; Collagen; Humans; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Serotonin; Sulfonamides; Thrombin; Thromboxane A2; Thromboxanes | 1985 |
BM 13.177 selectively inhibits endoperoxide analogue induced vascular contractions.
Topics: Animals; Fibrinolytic Agents; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Prostaglandin Endoperoxides, Synthetic; Rabbits; Sulfonamides | 1985 |
Inhibitory effects of the selective thromboxane receptor antagonist BM 13.177 on platelet aggregation, vasoconstriction and sudden death.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aorta; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Dinoprost; Humans; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Prostaglandins F; Rats; Receptors, Cell Surface; Receptors, Prostaglandin; Receptors, Thromboxane; Serotonin; Sulfonamides; Thromboxanes; Vasoconstriction | 1984 |
Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Collagen; Dose-Response Relationship, Drug; Epinephrine; Humans; Hydrogen Peroxide; Imidazoles; Indomethacin; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Prostaglandins E; Serotonin; Sulfonamides; Thromboxane A2; Thromboxane B2; Thromboxanes | 1984 |